We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

70 hedge funds and large institutions have $19.8M invested in Carisma Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more capital invested

Capital invested by funds: $11M → $19.8M (+$8.8M)

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

3% more funds holding

Funds holding: 68 → 70 (+2)

4% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $1.09M

0.16% more ownership

Funds ownership: 0.64% → 0.8% (+0.16%)

67% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 24

Holders
70
Holders Change
+2
Holders Change %
+2.94%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
8
Reduced
24
Closed
11
Calls
$1.14M
Puts
$1.09M
Net Calls
+$46K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$244K
2
Jane Street
Jane Street
New York
+$150K
3
BWA
Blodgett Wealth Advisors
California
+$143K
4
E
Ergoteles
New York
+$54.7K
5
CL
CSS LLC
Illinois
+$50.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$831K
2
BCM
Bridgeway Capital Management
Texas
-$106K
3
Millennium Management
Millennium Management
New York
-$94.3K
4
Morgan Stanley
Morgan Stanley
New York
-$83.7K
5
GCP
GSA Capital Partners
United Kingdom
-$80K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$30K – – –
ECM
27
ExodusPoint Capital Management
New York
$27K +$23K +2,190 New
WA
28
WealthTrust Axiom
Pennsylvania
$19.4K – – –
HF
29
HRT Financial
New York
$19K +$17K +1,619 New
IWM
30
IHT Wealth Management
Illinois
$18.4K – – –
VVP
31
Venture Visionary Partners
Ohio
$18.3K -$18.6K -1,767 -54%
OFG
32
Oxford Financial Group
Indiana
$18.3K – – –
GSC
33
Ground Swell Capital
South Carolina
$17.4K +$15K +1,427 New
Bank of America
34
Bank of America
North Carolina
$16.1K – – –
Mercer Global Advisors
35
Mercer Global Advisors
Colorado
$15K – – –
Two Sigma Advisers
36
Two Sigma Advisers
New York
$13.8K +$11.9K +1,130 New
Victory Capital Management
37
Victory Capital Management
Texas
$13.7K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$13.4K -$557 -53 -5%
Osaic Holdings
39
Osaic Holdings
Arizona
$13K -$4.81K -458 -30%
RJFSA
40
Raymond James Financial Services Advisors
Florida
$12.8K -$389 -37 -3%
FT
41
Fiduciary Trust
Massachusetts
$12.6K – – –
IAG
42
Investment Advisory Group
Massachusetts
$12.2K – – –
IWC
43
Integrated Wealth Concepts
Massachusetts
$12K – – –
IA
44
IFP Advisors
Florida
$11K – – –
PCS
45
Personal CFO Solutions
New Jersey
$11K – – –
CSS
46
Cubist Systematic Strategies
Connecticut
$9.64K +$8.31K +791 New
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$8.33K -$68.6K -6,537 -91%
SG
48
StoneX Group
New York
$7.92K +$6.83K +650 New
PIA
49
Perennial Investment Advisors
California
$7.31K – – –
LPL Financial
50
LPL Financial
California
$7.1K -$525 -50 -8%
1
2
3 4

CARM Hedge Fund Activity: Q4 2022 in Review

70 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2022, worth a combined $19.8M — up 80% from $11M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CARM positions and 11 closed out — a net gain of 2 holders — while 8 added to existing stakes and 24 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $244K. The largest seller was BlackRock, cutting an estimated $831K.

  • 70 institutional investors held Carisma Therapeutics (CARM) as of Q4 2022, up from 68 in Q3 2022.
  • Funds reported $19.8M of Carisma Therapeutics stock for Q4 2022, up 80% quarter-over-quarter.
  • 13 funds opened new Carisma Therapeutics positions in Q4 2022 and 11 closed out, a net change of +2 holders.
  • The largest Carisma Therapeutics buyer in Q4 2022 was Acadian Asset Management, an estimated $244K added.
  • The largest Carisma Therapeutics seller in Q4 2022 was BlackRock, an estimated $831K sold.

Based on aggregated 13F filings for Q4 2022.